Nivolumab-induced Third Degree Atrioventricular Block in a Patient with Stage IV Squamous Cell Lung Carcinoma

In the era of immune checkpoint inhibitors, pulmonary and critical care physicians frequently encounter patients taking these medications, usually after being admitted to the intensive care unit with life-threatening complications. These complications are rare, present with nonspecific and vague sym...

Descripción completa

Detalles Bibliográficos
Autores principales: Bukamur, Hazim S, Mezughi, Haitem, Karem, Emhemmid, Shahoub, Ibrahim, Shweihat, Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687417/
https://www.ncbi.nlm.nih.gov/pubmed/31417814
http://dx.doi.org/10.7759/cureus.4869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687417/
https://www.ncbi.nlm.nih.gov/pubmed/31417814
http://dx.doi.org/10.7759/cureus.4869

Ejemplares similares